REGENERON PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash
REGENERON PHARMACEUTICALS, INC. (REGN) reported Increase (Decrease) in Restricted Cash of $685.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-10-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2011-10-27
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2011-09-30 was $4.00K.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2010-12-31 was -$2.92M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2010-09-30 was $0.00.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2009-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2010 was -$1.12M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2009 was -$50.00K, a 200.00% decline from fiscal 2008.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2008 was $50.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2011-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $685.00K 10-Q · filed 2011-10-27 | ||
| 2011-06-30 | $681.00K 10-Q · filed 2011-07-28 | |||
| 2010-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | -$2.92M derived: sum of 2 quarters · filed 2011-10-27 | -$1.12M 10-K · filed 2011-02-17 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $1.80M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $1.80M 10-Q · filed 2011-07-28 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $0.00 derived: sum of 2 quarters · filed 2011-02-17 | -$50.00K 10-K · filed 2011-02-17 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$50.00K 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | -$50.00K 10-Q · filed 2010-07-28 | |||
| 2008-12-31 | $50.00K 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |